Related Experiment Video
Updated: May 8, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Cardiorenal syndrome by heart failure]
J Vítovec1, J Murín, L Spinarová
1Interni kardio-angiologicka klinika Lekarske fakulty MU a FN u sv Anny, ICRC Brno. jiri.vitovec@fnusa.cz
Abstract:
Cardiorenal (CR) syndrome is defined for the purposes of the following text mainly as primary cardiac dysfunction with a consequent failure of renal haemodynamics. Heart failure leads to a decrease in cardiac output and to the activation of vasoconstrictors; this gradually precipitates a decrease in the level of renal perfusion, the vasoconstriction of renal vessels and a decrease in glomerular filtration with a gradual development of renal failure. The following paper analyses the pathophysiological mechanisms, the characteristics of the patients, the role of medication during CR syndrome, the relationship between proteinuria and anaemia during CR syndrome and the application of bio-markers and pulmonary hypertension in the prognosis of patients with CR syndrome.
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure Drugs: Diuretics
Cardiomyopathy V: Interprofessional Care